马小军主任医师论治甲状腺癌术后综合征经验

Dr.Ma Xiaojun's Experience in Treating Postoperative Syndrome of Thyroid Cancer

近年甲状腺癌发病率持续上升,据世界卫生组织2020年流行病学研究,甲状腺癌在恶性肿瘤中居于第9位。手术及术后激素替代治疗是甲状腺癌最核心的治疗手段,目前我国甲状腺癌术后5年的相对存活率已提升至84.3%,同时手术治疗也会伴有多种术后综合征,西医治疗具有相对局限性,马小军主任根据多年行医经验,基于治病必求于本的原则,将甲状腺癌术后综合征分为肝郁气滞证、痰凝血瘀证以及气阴两虚证三种证型,分别进行论治。临床应用中患者不适症状均有不同程度的缓解,现梳理马师治疗甲状腺癌术后综合征的临床经验,以供参考。

In recent years,the incidence of thyroid cancer has continued to rise.According to the World Health Organization's 2020 epidemiological study,thyroid cancer ranks as the 9th most common malignant tumor.Surgery and postoperative hormone replacement therapy are the core treatments for thyroid cancer.Currently,the 5-year relative survival rate of thyroid cancer patients in China has increased to 84.3%.However,surgical treatments are also accompanied by a variety of postoperative syndromes,which are relatively limited by Western medicine.Based on years of medical experience,Dr.Ma Xiaojun has classified the postoperative syndrome of thyroid cancer into the syndrome of liver depression and stagnation,the syndrome of phlegm coagulation and blood stasis,and the syndrome of deficiency of qi and yin.In clinical application,patients' discomfort symptoms were relieved to different degrees.This paper summarizes Dr.Ma's clinical experience in treating postthyroidectomy syndrome for reference.